Medical Care

Global Ophthalmic Devices and Drugs Market Research Report 2025

The global market for Ophthalmic Devices and Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Ophthalmic devices and drugs are medical products designed for the diagnosis, treatment, and management of various eye-related conditions and disorders. These products cover a wide range of applications, from correcting refractive errors with eyeglasses to treating complex eye diseases with pharmaceutical interventions.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Devices and Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Devices and Drugs.
The Ophthalmic Devices and Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmic Devices and Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Devices and Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zeiss
Haag Streit
Topcon
Nidek
Essilor
Ziemer
Canon
Gulden Ophthalmics
Optovue
Quest Medical
Phoenix DeVentures
EyeKon Medical
FCI Ophthalmics
Atrion
Sterimedix
OPIA
IRIDEX
Jardon Eye Prosthetics
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Segment by Type
Ophthalmic Devices
Ophthalmic Drugs
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Devices and Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Devices and Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ophthalmic Devices
1.2.3 Ophthalmic Drugs
1.3 Market by Application
1.3.1 Global Ophthalmic Devices and Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Devices and Drugs Market Perspective (2020-2031)
2.2 Global Ophthalmic Devices and Drugs Growth Trends by Region
2.2.1 Global Ophthalmic Devices and Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ophthalmic Devices and Drugs Historic Market Size by Region (2020-2025)
2.2.3 Ophthalmic Devices and Drugs Forecasted Market Size by Region (2026-2031)
2.3 Ophthalmic Devices and Drugs Market Dynamics
2.3.1 Ophthalmic Devices and Drugs Industry Trends
2.3.2 Ophthalmic Devices and Drugs Market Drivers
2.3.3 Ophthalmic Devices and Drugs Market Challenges
2.3.4 Ophthalmic Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Devices and Drugs Players by Revenue
3.1.1 Global Top Ophthalmic Devices and Drugs Players by Revenue (2020-2025)
3.1.2 Global Ophthalmic Devices and Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Ophthalmic Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ophthalmic Devices and Drugs Revenue
3.4 Global Ophthalmic Devices and Drugs Market Concentration Ratio
3.4.1 Global Ophthalmic Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Devices and Drugs Revenue in 2024
3.5 Global Key Players of Ophthalmic Devices and Drugs Head office and Area Served
3.6 Global Key Players of Ophthalmic Devices and Drugs, Product and Application
3.7 Global Key Players of Ophthalmic Devices and Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Devices and Drugs Breakdown Data by Type
4.1 Global Ophthalmic Devices and Drugs Historic Market Size by Type (2020-2025)
4.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Type (2026-2031)
5 Ophthalmic Devices and Drugs Breakdown Data by Application
5.1 Global Ophthalmic Devices and Drugs Historic Market Size by Application (2020-2025)
5.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ophthalmic Devices and Drugs Market Size (2020-2031)
6.2 North America Ophthalmic Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ophthalmic Devices and Drugs Market Size by Country (2020-2025)
6.4 North America Ophthalmic Devices and Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ophthalmic Devices and Drugs Market Size (2020-2031)
7.2 Europe Ophthalmic Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ophthalmic Devices and Drugs Market Size by Country (2020-2025)
7.4 Europe Ophthalmic Devices and Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Devices and Drugs Market Size (2020-2031)
8.2 Asia-Pacific Ophthalmic Devices and Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ophthalmic Devices and Drugs Market Size (2020-2031)
9.2 Latin America Ophthalmic Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ophthalmic Devices and Drugs Market Size by Country (2020-2025)
9.4 Latin America Ophthalmic Devices and Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Devices and Drugs Market Size (2020-2031)
10.2 Middle East & Africa Ophthalmic Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zeiss
11.1.1 Zeiss Company Details
11.1.2 Zeiss Business Overview
11.1.3 Zeiss Ophthalmic Devices and Drugs Introduction
11.1.4 Zeiss Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.1.5 Zeiss Recent Development
11.2 Haag Streit
11.2.1 Haag Streit Company Details
11.2.2 Haag Streit Business Overview
11.2.3 Haag Streit Ophthalmic Devices and Drugs Introduction
11.2.4 Haag Streit Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.2.5 Haag Streit Recent Development
11.3 Topcon
11.3.1 Topcon Company Details
11.3.2 Topcon Business Overview
11.3.3 Topcon Ophthalmic Devices and Drugs Introduction
11.3.4 Topcon Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.3.5 Topcon Recent Development
11.4 Nidek
11.4.1 Nidek Company Details
11.4.2 Nidek Business Overview
11.4.3 Nidek Ophthalmic Devices and Drugs Introduction
11.4.4 Nidek Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.4.5 Nidek Recent Development
11.5 Essilor
11.5.1 Essilor Company Details
11.5.2 Essilor Business Overview
11.5.3 Essilor Ophthalmic Devices and Drugs Introduction
11.5.4 Essilor Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.5.5 Essilor Recent Development
11.6 Ziemer
11.6.1 Ziemer Company Details
11.6.2 Ziemer Business Overview
11.6.3 Ziemer Ophthalmic Devices and Drugs Introduction
11.6.4 Ziemer Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.6.5 Ziemer Recent Development
11.7 Canon
11.7.1 Canon Company Details
11.7.2 Canon Business Overview
11.7.3 Canon Ophthalmic Devices and Drugs Introduction
11.7.4 Canon Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.7.5 Canon Recent Development
11.8 Gulden Ophthalmics
11.8.1 Gulden Ophthalmics Company Details
11.8.2 Gulden Ophthalmics Business Overview
11.8.3 Gulden Ophthalmics Ophthalmic Devices and Drugs Introduction
11.8.4 Gulden Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.8.5 Gulden Ophthalmics Recent Development
11.9 Optovue
11.9.1 Optovue Company Details
11.9.2 Optovue Business Overview
11.9.3 Optovue Ophthalmic Devices and Drugs Introduction
11.9.4 Optovue Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.9.5 Optovue Recent Development
11.10 Quest Medical
11.10.1 Quest Medical Company Details
11.10.2 Quest Medical Business Overview
11.10.3 Quest Medical Ophthalmic Devices and Drugs Introduction
11.10.4 Quest Medical Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.10.5 Quest Medical Recent Development
11.11 Phoenix DeVentures
11.11.1 Phoenix DeVentures Company Details
11.11.2 Phoenix DeVentures Business Overview
11.11.3 Phoenix DeVentures Ophthalmic Devices and Drugs Introduction
11.11.4 Phoenix DeVentures Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.11.5 Phoenix DeVentures Recent Development
11.12 EyeKon Medical
11.12.1 EyeKon Medical Company Details
11.12.2 EyeKon Medical Business Overview
11.12.3 EyeKon Medical Ophthalmic Devices and Drugs Introduction
11.12.4 EyeKon Medical Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.12.5 EyeKon Medical Recent Development
11.13 FCI Ophthalmics
11.13.1 FCI Ophthalmics Company Details
11.13.2 FCI Ophthalmics Business Overview
11.13.3 FCI Ophthalmics Ophthalmic Devices and Drugs Introduction
11.13.4 FCI Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.13.5 FCI Ophthalmics Recent Development
11.14 Atrion
11.14.1 Atrion Company Details
11.14.2 Atrion Business Overview
11.14.3 Atrion Ophthalmic Devices and Drugs Introduction
11.14.4 Atrion Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.14.5 Atrion Recent Development
11.15 Sterimedix
11.15.1 Sterimedix Company Details
11.15.2 Sterimedix Business Overview
11.15.3 Sterimedix Ophthalmic Devices and Drugs Introduction
11.15.4 Sterimedix Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.15.5 Sterimedix Recent Development
11.16 OPIA
11.16.1 OPIA Company Details
11.16.2 OPIA Business Overview
11.16.3 OPIA Ophthalmic Devices and Drugs Introduction
11.16.4 OPIA Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.16.5 OPIA Recent Development
11.17 IRIDEX
11.17.1 IRIDEX Company Details
11.17.2 IRIDEX Business Overview
11.17.3 IRIDEX Ophthalmic Devices and Drugs Introduction
11.17.4 IRIDEX Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.17.5 IRIDEX Recent Development
11.18 Jardon Eye Prosthetics
11.18.1 Jardon Eye Prosthetics Company Details
11.18.2 Jardon Eye Prosthetics Business Overview
11.18.3 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Introduction
11.18.4 Jardon Eye Prosthetics Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.18.5 Jardon Eye Prosthetics Recent Development
11.19 Santen Pharmaceutical
11.19.1 Santen Pharmaceutical Company Details
11.19.2 Santen Pharmaceutical Business Overview
11.19.3 Santen Pharmaceutical Ophthalmic Devices and Drugs Introduction
11.19.4 Santen Pharmaceutical Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.19.5 Santen Pharmaceutical Recent Development
11.20 Bausch Health
11.20.1 Bausch Health Company Details
11.20.2 Bausch Health Business Overview
11.20.3 Bausch Health Ophthalmic Devices and Drugs Introduction
11.20.4 Bausch Health Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.20.5 Bausch Health Recent Development
11.21 Takeda
11.21.1 Takeda Company Details
11.21.2 Takeda Business Overview
11.21.3 Takeda Ophthalmic Devices and Drugs Introduction
11.21.4 Takeda Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.21.5 Takeda Recent Development
11.22 Novartis
11.22.1 Novartis Company Details
11.22.2 Novartis Business Overview
11.22.3 Novartis Ophthalmic Devices and Drugs Introduction
11.22.4 Novartis Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.22.5 Novartis Recent Development
11.23 Genentech
11.23.1 Genentech Company Details
11.23.2 Genentech Business Overview
11.23.3 Genentech Ophthalmic Devices and Drugs Introduction
11.23.4 Genentech Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.23.5 Genentech Recent Development
11.24 Allergan
11.24.1 Allergan Company Details
11.24.2 Allergan Business Overview
11.24.3 Allergan Ophthalmic Devices and Drugs Introduction
11.24.4 Allergan Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.24.5 Allergan Recent Development
11.25 Sun Pharmaceutical Industries
11.25.1 Sun Pharmaceutical Industries Company Details
11.25.2 Sun Pharmaceutical Industries Business Overview
11.25.3 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Introduction
11.25.4 Sun Pharmaceutical Industries Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.25.5 Sun Pharmaceutical Industries Recent Development
11.26 Actavis Generics
11.26.1 Actavis Generics Company Details
11.26.2 Actavis Generics Business Overview
11.26.3 Actavis Generics Ophthalmic Devices and Drugs Introduction
11.26.4 Actavis Generics Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.26.5 Actavis Generics Recent Development
11.27 Regeneron Pharmaceuticals
11.27.1 Regeneron Pharmaceuticals Company Details
11.27.2 Regeneron Pharmaceuticals Business Overview
11.27.3 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Introduction
11.27.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.27.5 Regeneron Pharmaceuticals Recent Development
11.28 Pfizer
11.28.1 Pfizer Company Details
11.28.2 Pfizer Business Overview
11.28.3 Pfizer Ophthalmic Devices and Drugs Introduction
11.28.4 Pfizer Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.28.5 Pfizer Recent Development
11.29 Johnson and Johnson
11.29.1 Johnson and Johnson Company Details
11.29.2 Johnson and Johnson Business Overview
11.29.3 Johnson and Johnson Ophthalmic Devices and Drugs Introduction
11.29.4 Johnson and Johnson Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.29.5 Johnson and Johnson Recent Development
11.30 Bausch and Lomb
11.30.1 Bausch and Lomb Company Details
11.30.2 Bausch and Lomb Business Overview
11.30.3 Bausch and Lomb Ophthalmic Devices and Drugs Introduction
11.30.4 Bausch and Lomb Revenue in Ophthalmic Devices and Drugs Business (2020-2025)
11.30.5 Bausch and Lomb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Ophthalmic Devices and Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ophthalmic Devices
Table 3. Key Players of Ophthalmic Drugs
Table 4. Global Ophthalmic Devices and Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Ophthalmic Devices and Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Ophthalmic Devices and Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Ophthalmic Devices and Drugs Market Share by Region (2020-2025)
Table 8. Global Ophthalmic Devices and Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Ophthalmic Devices and Drugs Market Share by Region (2026-2031)
Table 10. Ophthalmic Devices and Drugs Market Trends
Table 11. Ophthalmic Devices and Drugs Market Drivers
Table 12. Ophthalmic Devices and Drugs Market Challenges
Table 13. Ophthalmic Devices and Drugs Market Restraints
Table 14. Global Ophthalmic Devices and Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Ophthalmic Devices and Drugs Market Share by Players (2020-2025)
Table 16. Global Top Ophthalmic Devices and Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Devices and Drugs as of 2024)
Table 17. Ranking of Global Top Ophthalmic Devices and Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Ophthalmic Devices and Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Ophthalmic Devices and Drugs, Headquarters and Area Served
Table 20. Global Key Players of Ophthalmic Devices and Drugs, Product and Application
Table 21. Global Key Players of Ophthalmic Devices and Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ophthalmic Devices and Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Ophthalmic Devices and Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Ophthalmic Devices and Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Ophthalmic Devices and Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Ophthalmic Devices and Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Ophthalmic Devices and Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Ophthalmic Devices and Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Ophthalmic Devices and Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Ophthalmic Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Ophthalmic Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Ophthalmic Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Ophthalmic Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Ophthalmic Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Ophthalmic Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Ophthalmic Devices and Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Ophthalmic Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Ophthalmic Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Ophthalmic Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Ophthalmic Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Zeiss Company Details
Table 47. Zeiss Business Overview
Table 48. Zeiss Ophthalmic Devices and Drugs Product
Table 49. Zeiss Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 50. Zeiss Recent Development
Table 51. Haag Streit Company Details
Table 52. Haag Streit Business Overview
Table 53. Haag Streit Ophthalmic Devices and Drugs Product
Table 54. Haag Streit Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 55. Haag Streit Recent Development
Table 56. Topcon Company Details
Table 57. Topcon Business Overview
Table 58. Topcon Ophthalmic Devices and Drugs Product
Table 59. Topcon Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 60. Topcon Recent Development
Table 61. Nidek Company Details
Table 62. Nidek Business Overview
Table 63. Nidek Ophthalmic Devices and Drugs Product
Table 64. Nidek Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 65. Nidek Recent Development
Table 66. Essilor Company Details
Table 67. Essilor Business Overview
Table 68. Essilor Ophthalmic Devices and Drugs Product
Table 69. Essilor Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 70. Essilor Recent Development
Table 71. Ziemer Company Details
Table 72. Ziemer Business Overview
Table 73. Ziemer Ophthalmic Devices and Drugs Product
Table 74. Ziemer Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 75. Ziemer Recent Development
Table 76. Canon Company Details
Table 77. Canon Business Overview
Table 78. Canon Ophthalmic Devices and Drugs Product
Table 79. Canon Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 80. Canon Recent Development
Table 81. Gulden Ophthalmics Company Details
Table 82. Gulden Ophthalmics Business Overview
Table 83. Gulden Ophthalmics Ophthalmic Devices and Drugs Product
Table 84. Gulden Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 85. Gulden Ophthalmics Recent Development
Table 86. Optovue Company Details
Table 87. Optovue Business Overview
Table 88. Optovue Ophthalmic Devices and Drugs Product
Table 89. Optovue Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 90. Optovue Recent Development
Table 91. Quest Medical Company Details
Table 92. Quest Medical Business Overview
Table 93. Quest Medical Ophthalmic Devices and Drugs Product
Table 94. Quest Medical Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 95. Quest Medical Recent Development
Table 96. Phoenix DeVentures Company Details
Table 97. Phoenix DeVentures Business Overview
Table 98. Phoenix DeVentures Ophthalmic Devices and Drugs Product
Table 99. Phoenix DeVentures Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 100. Phoenix DeVentures Recent Development
Table 101. EyeKon Medical Company Details
Table 102. EyeKon Medical Business Overview
Table 103. EyeKon Medical Ophthalmic Devices and Drugs Product
Table 104. EyeKon Medical Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 105. EyeKon Medical Recent Development
Table 106. FCI Ophthalmics Company Details
Table 107. FCI Ophthalmics Business Overview
Table 108. FCI Ophthalmics Ophthalmic Devices and Drugs Product
Table 109. FCI Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 110. FCI Ophthalmics Recent Development
Table 111. Atrion Company Details
Table 112. Atrion Business Overview
Table 113. Atrion Ophthalmic Devices and Drugs Product
Table 114. Atrion Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 115. Atrion Recent Development
Table 116. Sterimedix Company Details
Table 117. Sterimedix Business Overview
Table 118. Sterimedix Ophthalmic Devices and Drugs Product
Table 119. Sterimedix Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 120. Sterimedix Recent Development
Table 121. OPIA Company Details
Table 122. OPIA Business Overview
Table 123. OPIA Ophthalmic Devices and Drugs Product
Table 124. OPIA Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 125. OPIA Recent Development
Table 126. IRIDEX Company Details
Table 127. IRIDEX Business Overview
Table 128. IRIDEX Ophthalmic Devices and Drugs Product
Table 129. IRIDEX Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 130. IRIDEX Recent Development
Table 131. Jardon Eye Prosthetics Company Details
Table 132. Jardon Eye Prosthetics Business Overview
Table 133. Jardon Eye Prosthetics Ophthalmic Devices and Drugs Product
Table 134. Jardon Eye Prosthetics Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 135. Jardon Eye Prosthetics Recent Development
Table 136. Santen Pharmaceutical Company Details
Table 137. Santen Pharmaceutical Business Overview
Table 138. Santen Pharmaceutical Ophthalmic Devices and Drugs Product
Table 139. Santen Pharmaceutical Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 140. Santen Pharmaceutical Recent Development
Table 141. Bausch Health Company Details
Table 142. Bausch Health Business Overview
Table 143. Bausch Health Ophthalmic Devices and Drugs Product
Table 144. Bausch Health Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 145. Bausch Health Recent Development
Table 146. Takeda Company Details
Table 147. Takeda Business Overview
Table 148. Takeda Ophthalmic Devices and Drugs Product
Table 149. Takeda Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 150. Takeda Recent Development
Table 151. Novartis Company Details
Table 152. Novartis Business Overview
Table 153. Novartis Ophthalmic Devices and Drugs Product
Table 154. Novartis Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 155. Novartis Recent Development
Table 156. Genentech Company Details
Table 157. Genentech Business Overview
Table 158. Genentech Ophthalmic Devices and Drugs Product
Table 159. Genentech Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 160. Genentech Recent Development
Table 161. Allergan Company Details
Table 162. Allergan Business Overview
Table 163. Allergan Ophthalmic Devices and Drugs Product
Table 164. Allergan Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 165. Allergan Recent Development
Table 166. Sun Pharmaceutical Industries Company Details
Table 167. Sun Pharmaceutical Industries Business Overview
Table 168. Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Product
Table 169. Sun Pharmaceutical Industries Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 170. Sun Pharmaceutical Industries Recent Development
Table 171. Actavis Generics Company Details
Table 172. Actavis Generics Business Overview
Table 173. Actavis Generics Ophthalmic Devices and Drugs Product
Table 174. Actavis Generics Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 175. Actavis Generics Recent Development
Table 176. Regeneron Pharmaceuticals Company Details
Table 177. Regeneron Pharmaceuticals Business Overview
Table 178. Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Product
Table 179. Regeneron Pharmaceuticals Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 180. Regeneron Pharmaceuticals Recent Development
Table 181. Pfizer Company Details
Table 182. Pfizer Business Overview
Table 183. Pfizer Ophthalmic Devices and Drugs Product
Table 184. Pfizer Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 185. Pfizer Recent Development
Table 186. Johnson and Johnson Company Details
Table 187. Johnson and Johnson Business Overview
Table 188. Johnson and Johnson Ophthalmic Devices and Drugs Product
Table 189. Johnson and Johnson Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 190. Johnson and Johnson Recent Development
Table 191. Bausch and Lomb Company Details
Table 192. Bausch and Lomb Business Overview
Table 193. Bausch and Lomb Ophthalmic Devices and Drugs Product
Table 194. Bausch and Lomb Revenue in Ophthalmic Devices and Drugs Business (2020-2025) & (US$ Million)
Table 195. Bausch and Lomb Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
Table 199. Authors List of This Report


List of Figures
Figure 1. Ophthalmic Devices and Drugs Picture
Figure 2. Global Ophthalmic Devices and Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ophthalmic Devices and Drugs Market Share by Type: 2024 VS 2031
Figure 4. Ophthalmic Devices Features
Figure 5. Ophthalmic Drugs Features
Figure 6. Global Ophthalmic Devices and Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Ophthalmic Devices and Drugs Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Ophthalmic Devices and Drugs Report Years Considered
Figure 12. Global Ophthalmic Devices and Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Ophthalmic Devices and Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Ophthalmic Devices and Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Ophthalmic Devices and Drugs Market Share by Players in 2024
Figure 16. Global Top Ophthalmic Devices and Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Devices and Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Ophthalmic Devices and Drugs Revenue in 2024
Figure 18. North America Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Ophthalmic Devices and Drugs Market Share by Country (2020-2031)
Figure 20. United States Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Ophthalmic Devices and Drugs Market Share by Country (2020-2031)
Figure 24. Germany Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Ophthalmic Devices and Drugs Market Share by Region (2020-2031)
Figure 32. China Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Ophthalmic Devices and Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Ophthalmic Devices and Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Ophthalmic Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Zeiss Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 48. Haag Streit Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 49. Topcon Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 50. Nidek Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 51. Essilor Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 52. Ziemer Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 53. Canon Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 54. Gulden Ophthalmics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 55. Optovue Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 56. Quest Medical Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 57. Phoenix DeVentures Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 58. EyeKon Medical Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 59. FCI Ophthalmics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 60. Atrion Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 61. Sterimedix Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 62. OPIA Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 63. IRIDEX Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 64. Jardon Eye Prosthetics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 65. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 66. Bausch Health Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 67. Takeda Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 68. Novartis Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 69. Genentech Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 70. Allergan Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 71. Sun Pharmaceutical Industries Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 72. Actavis Generics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 73. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 74. Pfizer Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 75. Johnson and Johnson Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 76. Bausch and Lomb Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2020-2025)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies